Page last updated: 2024-12-07

acetoacetyl coa

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Acetoacetyl CoA is a key intermediate in the biosynthesis of fatty acids, ketone bodies, and cholesterol. It is synthesized by the condensation of acetyl-CoA with another molecule of acetyl-CoA, catalyzed by the enzyme thiolase. Acetoacetyl CoA can be further metabolized by the enzyme HMG-CoA synthase to form HMG-CoA, a precursor to cholesterol. In the liver, acetoacetyl CoA can be converted to ketone bodies, such as acetoacetate and beta-hydroxybutyrate, during prolonged fasting or starvation. Acetoacetyl CoA is also an important precursor in the biosynthesis of terpenes and isoprenoids. Its importance in various metabolic pathways makes it a key target for research in areas like metabolic disorders, drug development, and understanding cellular processes.'

Cross-References

ID SourceID
PubMed CID92153
CHEBI ID15345
SCHEMBL ID60436
MeSH IDM0056355

Synonyms (41)

Synonym
gtpl3039
3-oxobutyroyl-coa
3-oxobutanoyl-coa
3-ketobutyroyl-coa
3-ketobutanoyl-coa
acetoacetylcoenzyme a
coenzyme a, s-acetoacetate
bofuranosyl]-
9h-purin-6-amine,9-[5-o-[[[[[(3r)-4-[[3-[[2-[(1,3-dioxobutyl)thio]ethyl]amino]-3-oxopropyl]amino]-3-hydroxy-2,2-dimethyl-4-oxobutyl]oxy]hydroxyphosphinyl]oxy]hydroxyphosphinyl]-3-o-phosphono-beta-d-ri
s-acetoacetyl-coa
s-acetoacetylcoenzyme a
3-acetoacetyl-coa
acetoacetyl coenzyme a
C00332
1420-36-6
ACETOACETYL-COA ,
CHEBI:15345
s-acetoacetyl-coenzyme a
s-acetoacetyl-coenzym a
3'-phosphoadenosine 5'-{3-[(3r)-3-hydroxy-2,2-dimethyl-4-oxo-4-{[3-oxo-3-({2-[(3-oxobutanoyl)sulfanyl]ethyl}amino)propyl]amino}butyl] dihydrogen diphosphate}
DB03059
1DUB
s-[2-[3-[[(2r)-4-[[[(2r,3s,4r,5r)-5-(6-aminopurin-9-yl)-4-hydroxy-3-phosphonooxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-hydroxyphosphoryl]oxy-2-hydroxy-3,3-dimethylbutanoyl]amino]propanoylamino]ethyl] 3-oxobutanethioate
einecs 215-815-9
acetoacetyl coa
SCHEMBL60436
coenzyme a, s-(3-oxobutanoate)
J-000542
acetoacetyl coenzyme a sodium salt
3-oxobutyryl-coenzyme a
3-acetoacetyl-coenzyme a
J-007581
s-{(9r,13s,15r)-17-[(2r,3s,4r,5r)-5-(6-amino-9h-purin-9-yl)-4-hydroxy-3-(phosphonooxy)tetrahydrofuran-2-yl]-9,13,15-trihydroxy-10,10-dimethyl-13,15-dioxido-4,8-dioxo-12,14,16-trioxa-3,7-diaza-13,15-diphosphaheptadec-1-yl} 3-oxobutanethioate (non-preferred
DTXSID30931292
Q2639429
3-oxobutyryl-coa
acetoacetyl-coa; (acyl-coa); [m+h]+;
acetoacetylcoenzyme a sodium salt hydrate
s-acetoacetate coenzyme a sodium salt hydrate
CS-0119038
HY-N7392
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (2)

RoleDescription
Escherichia coli metaboliteAny bacterial metabolite produced during a metabolic reaction in Escherichia coli.
mouse metaboliteAny mammalian metabolite produced during a metabolic reaction in a mouse (Mus musculus).
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (1)

ClassDescription
3-oxo-fatty acyl-CoAAn oxo fatty acyl-CoA that results from the formal condensation of the thiol group of coenzyme A with the carboxy group of any 3-oxo-fatty acid..
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Pathways (18)

PathwayProteinsCompounds
Butanoate metabolism ( Butanoate metabolism )1518
NAD+ + (S)-3-Hydroxy-butanoyl-CoA = NADH + Acetoacetyl-CoA ( Tryptophan degradation )44
Succinyl-CoA + Acetoacetic acid = Succinic acid + Acetoacetyl-CoA ( Valine,Leucine and Isoleucine degradation )14
2 Acetyl-CoA = CoA + Acetoacetyl-CoA ( Tryptophan degradation )23
Lysine degradation ( Lysine degradation )2029
NAD+ + (S)-3-Hydroxy-butanoyl-CoA = NADH + Acetoacetyl-CoA ( Lysine degradation )34
Tryptophan degradation ( Tryptophan degradation )6454
Valine,Leucine and Isoleucine degradation ( Valine,Leucine and Isoleucine degradation )2936
Ketogenesis and ketolysis89
Disorders in ketone body synthesis512
Disorders in ketolysis58
Mevalonate pathway010
Cholesterol biosynthesis pathway in hepatocytes1137
Metabolic Epileptic Disorders2589
superpathway of sterol biosynthesis050
Valine, leucine and isoleucine degradation034
Metabolism overview078
Tryptophan metabolism2342

Protein Targets (2)

Inhibition Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Chain A, 2-ENOYL-COA HYDRATASERattus norvegicus (Norway rat)Ki1.60001.60001.60001.6000AID977610
Chain B, 2-ENOYL-COA HYDRATASERattus norvegicus (Norway rat)Ki1.60001.60001.60001.6000AID977610
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (2)

Assay IDTitleYearJournalArticle
AID977610Experimentally measured binding affinity data (Ki) for protein-ligand complexes derived from PDB1996The EMBO journal, Oct-01, Volume: 15, Issue:19
Crystal structure of enoyl-coenzyme A (CoA) hydratase at 2.5 angstroms resolution: a spiral fold defines the CoA-binding pocket.
AID1811Experimentally measured binding affinity data derived from PDB1996The EMBO journal, Oct-01, Volume: 15, Issue:19
Crystal structure of enoyl-coenzyme A (CoA) hydratase at 2.5 angstroms resolution: a spiral fold defines the CoA-binding pocket.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (118)

TimeframeStudies, This Drug (%)All Drugs %
pre-199037 (31.36)18.7374
1990's20 (16.95)18.2507
2000's25 (21.19)29.6817
2010's34 (28.81)24.3611
2020's2 (1.69)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 83.85

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be very strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index83.85 (24.57)
Research Supply Index4.80 (2.92)
Research Growth Index4.56 (4.65)
Search Engine Demand Index145.97 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (83.85)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials1 (0.84%)5.53%
Reviews5 (4.20%)6.00%
Case Studies1 (0.84%)4.05%
Observational0 (0.00%)0.25%
Other112 (94.12%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]